In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis

Oyardı, ÖZLEM; Savage, Paul; Erturan, Zayre; Bozkurt-Guzel, Cagla

doi:10.1093/jac/dkaa434

In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis

Oyardı Ö., Savage P. B., Erturan Z., Bozkurt-Guzel C.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.76, sa.2, ss.443-450, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 76 Sayı: 2
Basım Tarihi: 2021
Doi Numarası: 10.1093/jac/dkaa434
Dergi Adı: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, CINAHL, EMBASE, Environment Index, MEDLINE, Veterinary Science Database
Sayfa Sayıları: ss.443-450
Gazi Üniversitesi Adresli: Hayır

Özet

Background: Stenotrophomonas maltophilia is a Gram-negative bacterium resistant to several antibiotics and its prevalence in cystic fibrosis (CF) patients is increasing.